Cargando…

The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity, dyslipidemia and type-2 diabetes mellitus. Bile acids (BAs) bind to the farnesoid X receptor (FXR) and G protein-coupled receptor 5 (TGR5), which are involved in lipid and glucose metabolism and energy expend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Yoshinao, Hara, Nagisa, Sugimoto, Ryosuke, Mifuji-Moroka, Rumi, Tanaka, Hideaki, Eguchi, Akiko, Iwasa, Motoh, Hasegawa, Hiroshi, Iwata, Kazuko, Takei, Yoshiyuki, Taguchi, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457917/ https://www.ncbi.nlm.nih.gov/pubmed/28381740 http://dx.doi.org/10.2169/internalmedicine.56.7796

Ejemplares similares

Branched-Chain Amino Acid Supplementation Reduces Oxidative Stress and Prolongs Survival in Rats with Advanced Liver Cirrhosis
por: Iwasa, Motoh, et al.
Publicado: (2013)

Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
por: Yoshikawa, Kyoko, et al.
Publicado: (2017)

Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans
por: Tamai, Yasuyuki, et al.
Publicado: (2022)

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2020)

Complement complex 1 subunit q‐mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases
por: Eguchi, Akiko, et al.
Publicado: (2022)

Circulating Extracellular Vesicles and Their miR “Barcode” Differentiate Alcohol Drinkers With Liver Injury and Those Without Liver Injury in Severe Trauma Patients
por: Eguchi, Akiko, et al.
Publicado: (2019)

Protein Composition of Circulating Extracellular Vesicles Immediately Changed by Particular Short Time of High-Intensity Interval Training Exercise
por: Kobayashi, Yoshinao, et al.
Publicado: (2021)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
por: Iwasa, Motoh, et al.
Publicado: (2021)

Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma
por: Eguchi, Akiko, et al.
Publicado: (2019)

Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites
por: Shigefuku, Ryuta, et al.
Publicado: (2021)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab
por: Shigefuku, Ryuta, et al.
Publicado: (2022)

Development of a New Index to Distinguish Hepatic Encephalopathy through Automated Quantification of Globus Pallidal Signal Intensity Using MRI
por: Tamai, Yasuyuki, et al.
Publicado: (2022)

Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
por: Iwasa, Motoh, et al.
Publicado: (2019)

The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage
por: Eguchi, Akiko, et al.
Publicado: (2022)

A Rare Presentation of Intraperitoneal Ectopic Varices Rupture
por: Shigefuku, Ryuta, et al.
Publicado: (2020)

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
por: Eguchi, Akiko, et al.
Publicado: (2022)

Unidentified virus-like particles are detected in plasmas with elevated ALT levels: are they significant of etiological agent(s) of non-B, non-C hepatitis?
por: Kaito, Masahiko, et al.
Publicado: (2007)

Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease
por: Iwasa, Motoh, et al.
Publicado: (2022)

The role of bile acid metabolism in the occurrence and development of NAFLD
por: Bing, Hao, et al.
Publicado: (2022)

Successful endoscopic cyanoacrylate injection therapy for ruptured duodenal varices immediately after balloon‐occluded retrograde transvenous obliteration
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes
por: Weaver, Michael J., et al.
Publicado: (2020)

Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan
por: Hanai, Tatsunori, et al.
Publicado: (2021)

Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Tauriainen, Milla-Maria, et al.
Publicado: (2018)

Does Level of Social Capital Predict Perceived Health in a Community?—A Study of Adult Residents of Low-income Areas of Francistown, Botswana
por: Modie-Moroka, Tirelo
Publicado: (2009)

Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD
por: Smirnova, Ekaterina, et al.
Publicado: (2022)

Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
por: Liu, Jianjun, et al.
Publicado: (2023)

Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
por: Gottlieb, Aline, et al.
Publicado: (2019)

Evaluation of the Cell Block Method Using Overnight-Stored Bile for Malignant Biliary Stricture Diagnosis
por: Okuno, Mitsuru, et al.
Publicado: (2022)

Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Plat, Jogchum, et al.
Publicado: (2018)

Solitary pulmonary nodule of benign metastasizing leiomyoma associated with primary lung cancer: a case report
por: Naito, Masahiro, et al.
Publicado: (2011)

Signet Ring Cell Carcinoma of the Extrahepatic Bile Duct Diagnosed by Preoperative Biopsy: A Case Report
por: Kita, Emiri, et al.
Publicado: (2014)

Cyclooxygenase 2 Modulates Killing of Cytotoxic T Lymphocytes by Colon Cancer Cells
por: Wang, Quanxin, et al.
Publicado: (2009)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Awareness and Treatment of Alcohol Dependence in Japan: Results from Internet-Based Surveys in Persons, Family, Physicians and Society
por: Taguchi, Yurie, et al.
Publicado: (2014)

Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model
por: Huang, Wenli, et al.
Publicado: (2020)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Matsui, Masahiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7uh9nkbde0cfp2g9de1qbjj580